Biomarkers for skin involvement and fibrotic activity in scleroderma. - Wikidata - wikimedia - TriplyDB

Biomarkers for skin involvement and fibrotic activity in scleroderma.

Biomarkers for skin involvement and fibrotic activity in scleroderma.

http://www.wikidata.org/entity/Q37912251

about

Pharmacology and rationale for imatinib in the treatment of scleroderma A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis N-TproBNP as biomarker in systemic sclerosis.Quantitating skin fibrosis: innovative strategies and their clinical implications.Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease.Biomarkers in systemic sclerosis: Their potential to predict clinical courses.The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis.Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis.Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis.Serum galectin-3 level in systemic sclerosis.Shell extracts of the edible mussel and oyster induce an enhancement of the catabolic pathway of human skin fibroblasts, in vitro.

P2860

Q26825153-425DDC89-A4A7-4EDE-B021-BECE7FED7199 Q35587696-45B70B83-E0F0-4473-9672-95DA870E9174 Q38016375-131E398A-9FD3-4689-B95E-6A566E8C646A Q38180018-40ADAD2B-9AE7-4A60-BDDF-A70E2AAE349A Q38204104-3CD75BFB-F318-4D4E-89EA-5F8ED5255EDF Q38701985-031FAC66-5B59-4028-968B-B7D109E3CA95 Q40099352-6AB19632-1640-460B-8492-4BB9BF49EB3C Q42638573-E70558A9-5675-43D3-9D6F-D968405CB63F Q47400242-654BBAA1-F8C6-4E33-A20B-A364E9B94205 Q47866004-217AE134-1C20-4AD3-B381-26EFA7A599F7 Q50176319-A1C6D3D1-B46F-4204-AF33-B6F84C1F8904

P2860

Biomarkers for skin involvement and fibrotic activity in scleroderma.

http://www.wikidata.org/entity/Q37912251

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Biomarkers for skin involvement and fibrotic activity in scleroderma.

@en

Biomarkers for skin involvement and fibrotic activity in scleroderma.

@nl

type

label

Biomarkers for skin involvement and fibrotic activity in scleroderma.

@en

Biomarkers for skin involvement and fibrotic activity in scleroderma.

@nl

prefLabel

Biomarkers for skin involvement and fibrotic activity in scleroderma.

@en

Biomarkers for skin involvement and fibrotic activity in scleroderma.

@nl

P1433

Q37912251-1464A14C-0088-471C-ADCA-5905288F18CD

P1476

Q37912251-886C4277-7A5F-441D-83D9-160F33BA56D0

P2093

Q37912251-1BC20E2D-4C83-4DD6-823A-6792790E9BEF

Q37912251-20CF64A1-EAF9-4FA4-B32E-FABFA70AA4EB

Q37912251-3AC08CEF-959C-4295-8C2B-1EA1E0CDB093

Q37912251-60C9A95B-C51B-4321-9264-C608D412C52C

Q37912251-6EDA5BC5-C695-4E55-B900-13F22A68366C

Q37912251-943BDB3E-F3F5-42C5-B325-3448D5A08653

Q37912251-F0774BA8-DA6B-45CC-B54F-332281D459CA

P2860

Q37912251-092799A7-E740-4D80-9C92-F072C527CC59

Q37912251-0E9D2905-9A50-4947-8EFB-EAE8276023DC

Q37912251-10324C97-114F-4E9A-8AE8-FFABD98C385D

Q37912251-20BE0005-B226-484D-968A-877B4012AF5A

Q37912251-2201E2FD-DDF2-480C-85A2-B7FBAAAC3F5E

Q37912251-257E7075-5447-4F26-B5B7-AA3E184635D8

Q37912251-2680743E-6B87-4B6C-ABB9-6B0BBBC42110

Q37912251-2DA80FFC-A8DA-44F7-841F-0792515FD5CB

Q37912251-32755FA4-94F6-45C7-9E51-F391FBAB9094

Q37912251-3C50E808-A5C5-4827-B934-0B8B0ECF9F83

P304

Q37912251-857628CD-8A9A-41D7-A7FF-14B6F84F27FD

P31

Q37912251-2A9F1810-CAD5-448C-B5C4-408AFA3B84E2

P356

Q37912251-257388CD-8AC8-43C9-9D4A-17E91191DBD2

P433

Q37912251-78E5FA00-1B90-46EB-BDDA-88CECEAAF666

P478

Q37912251-F87574B8-25C1-4AFB-979F-3CB63278D37A

P577

Q37912251-2D5BBD99-9D82-4684-B382-80A27F8B88E8

P698

Q37912251-F1816CC7-C934-4DC5-ACCC-C5096EFABFD7

P921

Q37912251-AB863537-1F41-4B5C-9387-5BA6CAAEDE58

P356

J.1468-3083.2011.04206.X

P1433

Journal of the European Academy of Dermatology and Venereology

P1476

Biomarkers for skin involvement and fibrotic activity in scleroderma.

@en

P2093

B Eckes

http://www.w3.org/2001/XMLSchema#string

C P Denton

http://www.w3.org/2001/XMLSchema#string

D Abraham

http://www.w3.org/2001/XMLSchema#string

N Hunzelmann

http://www.w3.org/2001/XMLSchema#string

P Moinzadeh

http://www.w3.org/2001/XMLSchema#string

T Krieg

http://www.w3.org/2001/XMLSchema#string

V Ong

http://www.w3.org/2001/XMLSchema#string

P2860

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis

Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis

TGF-beta signaling and the fibrotic response

Molecular subsets in the gene expression signatures of scleroderma skin.

Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H

Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.

Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis.

B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.

Cyclophosphamide versus placebo in scleroderma lung disease.

P304

267-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-3083.2011.04206.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21819452

http://www.w3.org/2001/XMLSchema#string

P921